DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.nature.com/articles/1203222, but it redirected us to https://www.nature.com/articles/1203222. The analysis below is for the second page.

Title[redir]:
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel | Oncogene
Description:
The avian Rev-T retrovirus encodes the v-Rel oncoprotein, which is a member of the Rel/NF-κB transcription factor family. v-Rel induces a rapidly fatal lymphoma/leukemia in young birds, and v-Rel can transform and immortalize a variety of avian cell types in vitro. Although Rel/NF-κB transcription factors have been associated with oncogenesis in mammals, v-Rel is the only member of this family that is frankly oncogenic in animal model systems. The potent oncogenicity of v-Rel is the consequence of a number of mutations that have altered its activity and regulation: for example, certain mutations decrease its ability to be regulated by IκBα, change its DNA-binding site specificity, and endow it with new transactivation properties. The study of v-Rel will continue to increase our knowledge of how cellular Rel proteins contribute to oncogenesis by affecting cell growth, altering cell-cycle regulation, and blocking apoptosis. This review will discuss biological and molecular activities of v-Rel, with particular attention to how these activities relate to structure – function aspects of the Rel/NF-κB transcription factors.

Matching Content Categories {📚}

Telecommunications
Science
Education

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month

Based on our best estimate, this website will receive around 96,105,781 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

oncogene, virol, bose, cell, gilmore, biol, mol, enrietto, virology, temin, nature, gélinas, avian, vrel, access, natl, usa, dis, article, hannink, humphries, cancer, proc, acad, sci, chen, hrdlicková, rice, content, nfκb, kabrun, olson, zhang, bargmann, white, research, cookies, nehyba, res, witter, privacy, open, walker, capobianco, mosialos, gilden, lim, press, genes, data,

Topics {✒️}

nature portfolio permissions reprints rel/nf-κb transcription factors privacy policy 1981 nature 294 nature author information authors advertising scientific legacy social media retroviral oncoprotein v-rel literature research tobacco research research nf-κb pathway personal data rapidly fatal lymphoma/leukemia springerlink instant access nf-κb data protection permissions v-rel oncoprotein dna-binding site specificity altering cell-cycle regulation v-rel induces privacy multiple mutations contribute explore content subscription content 1999 gene expression li c-ch european economic area animal model systems institutional subscriptions read antigen receptor-activated bose jr hr min-min wan noori-daloii mr hr bose jr accepting optional cookies journals search log affecting cell growth v-rel article purchase manage preferences structure – function aspects elsevier science publishers b-cell lymphoma content article gilmore

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
         description:The avian Rev-T retrovirus encodes the v-Rel oncoprotein, which is a member of the Rel/NF-ÎºB transcription factor family. v-Rel induces a rapidly fatal lymphoma/leukemia in young birds, and v-Rel can transform and immortalize a variety of avian cell types in vitro. Although Rel/NF-ÎºB transcription factors have been associated with oncogenesis in mammals, v-Rel is the only member of this family that is frankly oncogenic in animal model systems. The potent oncogenicity of v-Rel is the consequence of a number of mutations that have altered its activity and regulation: for example, certain mutations decrease its ability to be regulated by IÎºBÎ±, change its DNA-binding site specificity, and endow it with new transactivation properties. The study of v-Rel will continue to increase our knowledge of how cellular Rel proteins contribute to oncogenesis by affecting cell growth, altering cell-cycle regulation, and blocking apoptosis. This review will discuss biological and molecular activities of v-Rel, with particular attention to how these activities relate to structureâââfunction aspects of the Rel/NF-ÎºB transcription factors.
         datePublished:1999-11-22T00:00:00Z
         dateModified:1999-11-22T00:00:00Z
         pageStart:6925
         pageEnd:6937
         sameAs:https://doi.org/10.1038/sj.onc.1203222
         keywords:
            v-Rel
            Rel
            NF-ÎºB
            malignant transformation
            transcription factor
            retroviral oncogene
            Medicine/Public Health
            general
            Internal Medicine
            Cell Biology
            Human Genetics
            Oncology
            Apoptosis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1203222/MediaObjects/41388_1999_Article_BF1203222_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1203222/MediaObjects/41388_1999_Article_BF1203222_Fig2_HTML.jpg
         isPartOf:
            name:Oncogene
            issn:
               1476-5594
               0950-9232
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Thomas D Gilmore
               affiliation:
                     name:Boston University
                     address:
                        name:Biology Department, Boston University, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
      description:The avian Rev-T retrovirus encodes the v-Rel oncoprotein, which is a member of the Rel/NF-ÎºB transcription factor family. v-Rel induces a rapidly fatal lymphoma/leukemia in young birds, and v-Rel can transform and immortalize a variety of avian cell types in vitro. Although Rel/NF-ÎºB transcription factors have been associated with oncogenesis in mammals, v-Rel is the only member of this family that is frankly oncogenic in animal model systems. The potent oncogenicity of v-Rel is the consequence of a number of mutations that have altered its activity and regulation: for example, certain mutations decrease its ability to be regulated by IÎºBÎ±, change its DNA-binding site specificity, and endow it with new transactivation properties. The study of v-Rel will continue to increase our knowledge of how cellular Rel proteins contribute to oncogenesis by affecting cell growth, altering cell-cycle regulation, and blocking apoptosis. This review will discuss biological and molecular activities of v-Rel, with particular attention to how these activities relate to structureâââfunction aspects of the Rel/NF-ÎºB transcription factors.
      datePublished:1999-11-22T00:00:00Z
      dateModified:1999-11-22T00:00:00Z
      pageStart:6925
      pageEnd:6937
      sameAs:https://doi.org/10.1038/sj.onc.1203222
      keywords:
         v-Rel
         Rel
         NF-ÎºB
         malignant transformation
         transcription factor
         retroviral oncogene
         Medicine/Public Health
         general
         Internal Medicine
         Cell Biology
         Human Genetics
         Oncology
         Apoptosis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1203222/MediaObjects/41388_1999_Article_BF1203222_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fsj.onc.1203222/MediaObjects/41388_1999_Article_BF1203222_Fig2_HTML.jpg
      isPartOf:
         name:Oncogene
         issn:
            1476-5594
            0950-9232
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Thomas D Gilmore
            affiliation:
                  name:Boston University
                  address:
                     name:Biology Department, Boston University, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Oncogene
      issn:
         1476-5594
         0950-9232
      volumeNumber:18
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Boston University
      address:
         name:Biology Department, Boston University, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Thomas D Gilmore
      affiliation:
            name:Boston University
            address:
               name:Biology Department, Boston University, Boston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Biology Department, Boston University, Boston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(1)

https://twitter.com/oncogenejournal

External Links {🔗}(99)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

3.9s.